Cisplatin-induced posterior reversible encephalopathy syndrome and successful re-treatment in a patient with non-seminomatous germ cell tumor: a case report
Author:
Publisher
Springer Science and Business Media LLC
Subject
General Medicine
Link
http://link.springer.com/article/10.1186/1752-1947-6-409/fulltext.html
Reference10 articles.
1. Berman IJ, Mann MP: Seizures and transient cortical blindness associated with cis-platinum (II) diamminedichloride (PDD) therapy in a thirty-year-old man. Cancer. 1980, 45: 764-766. 10.1002/1097-0142(19800215)45:4<764::AID-CNCR2820450425>3.0.CO;2-G.
2. Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A, Pessin MS, Lamy C, Mas JL, Caplan LR: A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 1996, 334: 494-500. 10.1056/NEJM199602223340803.
3. Kaplan RS, Wiernik PH: Neurotoxicity of antineoplastic drugs. Semin Oncol. 1982, 9: 103-130.
4. Stott VL, Hurrell MA, Anderson TJ: Reversible posterior leukoencephalopathy syndrome: a misnomer reviewed. Intern Med J. 2005, 35: 83-90. 10.1111/j.1445-5994.2004.00750.x.
5. Fugate JE, Claassen DO, Cloft HJ, Kallmes DF, Kozak OS, Rabinstein AA: Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings. Mayo Clin Proc. 2010, 85: 427-432. 10.4065/mcp.2009.0590.
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Posterior reversible encephalopathy syndrome (PRES) in classic Hodgkin’s lymphoma, complicated by anthracycline-induced cardiomyopathy;BMJ Case Reports;2024-08
2. Management of Cisplatin-Induced Encephalopathy: A Case Report and Literature Review;Cureus;2024-06-11
3. The Survival Outcomes, Prognostic Factors and Adverse Events following Systemic Chemotherapy Treatment in Bone Sarcomas: A Retrospective Observational Study from the Experience of the Cancer Referral Center in Northern Thailand;Cancers;2023-03-26
4. Neurotoxic complications of chemotherapy in children: posterior reversible encephalopathy syndrome;Ural Medical Journal;2021-12-04
5. Complex Metal Ions: Neuropsychiatric and Imaging Features;The Journal of Neuropsychiatry and Clinical Neurosciences;2020-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3